Journal article

Therapy for secondary arthropathies.: From psoriasis and Reiter's disease to hemochromatosis


Authors listGoedde, A.; Mueller-Ladner, U.

Publication year2006

Pages1263-1268

JournalDer Internist

Volume number47

Issue number12

ISSN0020-9554

eISSN1432-1289

DOI Linkhttps://doi.org/10.1007/s00108-006-1754-0

PublisherSpringer


Abstract
Arthralgia is one of the most common complaints in Western society. The classification of joint diseases with respect to genesis is crucial for the determination of adequate treatment. For inflammatory arthropathies, treatment options have expanded significantly over the last decade. This review summarizes the current treatment of psoriatic arthritis and Reiter's disease, both belonging to the spectrum of seronegative spondyloarthropathies. Regardless of our increasing knowledge of chondrogenesis, the treatment of osteoarthritis is still more or less symptomatic. Premature age of onset and the atypical joint distribution of osteoarthritis should bring metabolic diseases, for example hemochromatosis, into consideration.



Citation Styles

Harvard Citation styleGoedde, A. and Mueller-Ladner, U. (2006) Therapy for secondary arthropathies.: From psoriasis and Reiter's disease to hemochromatosis, Der Internist, 47(12), pp. 1263-1268. https://doi.org/10.1007/s00108-006-1754-0

APA Citation styleGoedde, A., & Mueller-Ladner, U. (2006). Therapy for secondary arthropathies.: From psoriasis and Reiter's disease to hemochromatosis. Der Internist. 47(12), 1263-1268. https://doi.org/10.1007/s00108-006-1754-0



Keywords


ARTHROPATHYCLINICAL-TRIALCONTROLLED TRIALCYCLOSPORINEDOUBLE-BLINDHEMOCHROMATOSISMETHOTREXATE THERAPYPLACEBOPsoriatic arthritisREACTIVE ARTHRITISspondyloarthropathySULFASALAZINE

Last updated on 2025-02-04 at 03:48